United Therapeutics
UTHR
UTHR
400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.49% more ownership
Funds ownership: 100.54% → 101.03% (+0.49%)
3% less repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 139
11% less call options, than puts
Call options by funds: $20.4M | Put options by funds: $23M
Holders
400
Holding in Top 10
6
Calls
$20.4M
Puts
$23M
Top Buyers
| 1 | +$54.8M | |
| 2 | +$46.3M | |
| 3 | +$28.4M | |
| 4 |
Renaissance Technologies
New York
|
+$28M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$24.2M |
Top Sellers
| 1 | -$50.7M | |
| 2 | -$36.6M | |
| 3 | -$36.5M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$28.2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$25.2M |